Zydus Cadila Gets Warning Letter

Addresses FDA Warning Over Moraiya Plant And Commits To Respond

Zydus Cadila has received a warning letter from the FDA for its Moraiya facility. The company has insisted that it will not affect the existing business in the US where it has filed over 330 ANDAs.

Zydus_Magnified
Zydus gets in trouble with the FDA over compliance issues at its Moraiya facility • Source: Shutterstock

Zydus Cadila has disclosed that the company has received a warning letter from the US Food and Drug Administration relating to its Moraiya formulation facility, based in Gujarat, India. After the warning letter, the firm’s shares slipped a few points on the Bombay Stock Exchange.

According to Zydus, the company “has taken multiple steps after the inspection to address the observations received from the FDA...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business